Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Mise à jour : Il y a 5 ans
Référence : NCT02847650

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.


Critère d'inclusion

  • Parkinson disease


Liens